Spectrum pharma stock.
As a senior, you deserve to make the most out of your Spectrum subscription. With a wide array of services and offers available, it’s important to know how to navigate through them and find the best deals that suit your needs.
According to 4 analyst offering 12-month price targets in the last 3 months, Spectrum Pharma has an average price target of $3.19 with a high of $4.00 and a low of $0.75.Spectrum Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement SA News Wed, May 17 Spectrum Pharmaceuticals GAAP EPS of -$0.02 beats by $0.03, revenue of $15.6M beats by $1.44MA high-level overview of Assertio Holdings, Inc. (ASRT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.will acquire Spectrum Pharmaceuticals Inc SPPI in an all-stock and contingent value rights (CVR) transaction. Under the terms of the agreement, each Spectrum share will be exchanged for a...View %COMPANY_NAME% SPPI investment & stock information. Get the latest %COMPANY_NAME% SPPI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... Spectrum Pharmaceuticals ...
Spectrum Pharma Stock Earnings. The value each SPPI share was expected to gain vs. the value that each SPPI share actually gained. Spectrum Pharma ( SPPI) reported Q1 2023 earnings per share (EPS) of -$0.02, beating estimates of -$0.06 by 61.25%. In the same quarter last year, Spectrum Pharma 's earnings per share (EPS) was -$0.09. Apr 25, 2023 · By William White, InvestorPlace Writer Apr 25, 2023. Spectrum Pharmaceuticals (SPPI) stock is soaring higher on Tuesday thanks to a $291 million acquisition deal with Assertio (ASRT). On this news, Spectrum Pharmaceuticals’ stock price fell more than 21%, damaging investors. Investors who purchased or otherwise acquired shares of Spectrum Pharmaceuticals during the Class Period should contact the Firm prior to the November 1, 2021 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on …
Jan 18, 2019 ... Ahead of the announcement, shares of Aurobindo Pharma fell 1.62% to ₹ 774.3 on BSE, while the benchmark Sensex gained 0.15%. Milestone ...Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.
Based on 3 Wall Street analysts offering 12 month price targets for Spectrum Pharmaceuticals in the last 3 months. The average price target is $1.32 with a high forecast of $1.50 and a low forecast of $1.14. The average price target represents a Spectrum Pharmaceuticals focuses on developing and commercializing novel and targeted drug products, with a primary focus in oncology. ... The stock currently trades around $1.25 a share and ...Hyderabad, India, 17th January 2019: Aurobindo Pharma Limited (BSE: 524804 and NSE: AUROPHARMA) “Aurobindo”), announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also brings-in an experienced branded …Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients and has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. The Company has grown through business development including licensing, mergers, and acquisitions and is interested in ...
Track Spectrum Pharmaceuticals, Inc. (SPPI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
The Spectrum Pharmaceuticals class action lawsuit (Luo v. Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. , No. 2:21-cv-01612) was commenced on August 31, 2021 in the District of Nevada.
May 9, 2023 · Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 60% and 27.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? Apr 25, 2023 · Spectrum Stockholders Will Receive Upfront Consideration of 0.1783 ASRT shares per SPPI Share ($1.14 per share) Plus One CVR for Total Potential Consideration of up to $1.34 per Share Upfront... That deal values SPPI stock at $1.34 per share, which is a 94% premium over the stock’s closing price on Monday. It also brings the total value of the deal to $291 million. When the deal closes ...Spectrum Pharmaceuticals (SPPI) lost ~14% pre-market Friday after the biotech announced that the FDA declined to approve its New Drug Application ((NDA)) for tyrosine kinase...Spectrum Pharmaceuticals (NASDAQ:SPPI) has a recorded net income of -$75.40 million. SPPI has generated -$0.36 earnings per share over the last four quarters.Computershare Investor Services. P.O. Box 43023. Providence, RI 02940-3023. Telephone: +1 (781)-575-2879. The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.The 52-week high for Spectrum Pharmaceuticals Stock is $1.36 and the 52-week low is $0.315. What is the market capitalization of Spectrum Pharmaceuticals Stock? As of the 2023-10-30, the market capitalization of Spectrum Pharmaceuticals is 210.377M.
On this news, Spectrum Pharmaceuticals’ stock price fell 31% to close at $0.43 per share on September 23, 2022, on unusually heavy trading volume.Hanmi Pharmaceutical Confirms Possibility of Developing Innovative New Drugs for Rare Diseases Jun 22, 2023; ALL NEWS page move. Open Innovation Share Your Idea page move. IR Center Investor Relations page move. ... Stock Quotes (2023/11/29 15:30) ...Spectrum Pharmaceuticals, Inc. : News, information and stories for Spectrum Pharmaceuticals, Inc. | Nasdaq: SPPI | NasdaqMar 2, 2019 ... Aurobindo completes acquisition of cancer drug portfolio from Spectrum Pharma. Updated - December 06, 2021 at 09:29 PM. | Hyderabad, March 2. By ...Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001
... stock options.” To keep ... Satraplatin currently is being developed through a licensing agreement between Spectrum Pharmaceuticals and a German biotech company.Spectrum Equity provides growth capital and expertise to market leading companies.
5 Wall Street analysts have issued 1-year target prices for Checkpoint Therapeutics' stock. Their CKPT share price targets range from $14.00 to $47.00. On average, they anticipate the company's share price to reach $24.80 in the next year. This suggests a possible upside of 792.1% from the stock's current price.Spectrum Pharmaceuticals is a biopharmaceutical company whose products under development include, among others, ROLONTIS (eflapegrastim), a novel long-acting granulocyte colony-stimulating factor ...The Spectrum Pharmaceuticals class action lawsuit (Luo v. Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. , No. 2:21-cv-01612) was commenced on August 31, 2021 in the District of Nevada.Spectrum Pharmaceuticals (SPPI) Insider Trading & Ownership. Notice: This company has been marked as potentially delisted and may not be actively trading. Compare. Today's Range. $1.03.Stock and Other Ownership Interests - Spectrum Pharmaceuticals. Travel, Accommodations, Expenses - Spectrum Pharmaceuticals ... Research Funding - Bristol-Myers Squibb (Inst); Spectrum Pharmaceuticals (Inst) Travel, Accommodations, Expenses …Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance. Stock and Other Ownership Interests - Spectrum Pharmaceuticals. Travel, Accommodations, Expenses - Spectrum Pharmaceuticals ... Research Funding - Bristol-Myers Squibb (Inst); Spectrum Pharmaceuticals (Inst) Travel, Accommodations, Expenses …If you’re in the market for a basic cable package, Spectrum has you covered. With a wide range of channels and exciting features, Spectrum’s basic cable package offers great value for your entertainment needs.Equities. Stock Spectrum Pharmaceuticals, Inc. - Nasdaq. Spectrum Pharmaceuticals, Inc. (SPPI.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Spectrum Pharmaceuticals, Inc. | Nasdaq: SPPI | Nasdaq.
Mar. 18, 2022, 02:05 PM. HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ:SPPI), with a price target of $10. The analyst projects revenues of $170 million for ...
Spectrum Pharmaceuticals (SPPI) stock jumped 10.4% afterhours on Friday after the U.S. Food and Drug Administration approved its Rolvedon injection.The injection is used to treat chemoth...
At a special meeting held on July 27, 2023 the shareholders of Spectrum Pharmaceuticals, Inc. (SPPI) approved a merger with Assertio Holdings, Inc. (ASRT). The merger closed prior to the market open on August 1, 2023. In anticipation of the closing, the stock was halted immediately following the after-hours session at 8 p.m. on July 31, 2023.Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ('Spectrum' or the 'Company'), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Spectrum's New Drug Application (NDA) for poziotinib for the treatment of patients with previously ...Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.Spectrum Pharmaceuticals is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology. After a deal valued at $248 million was announced in April 2023, Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based …Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.Price/Book 7.89 Trade SPPI with: Price/Earnings ttm 0.00 Earnings Per Share ttm -0.37 Most Recent Earnings -0.02 on 05/09/23 Next Earnings Date 08/10/23 Annual Dividend & Yield N/A (0.00%) Most Recent Dividend 0.150 on 12/18/12 Sectors: Options Overview Details View History Implied Volatility 0.00% ( unch) Historical Volatility 41.98%Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Full title of the plan) 11500 South Eastern Avenue, Suite 220 . Henderson, Nevada 89052 ... The Registrant previously registered shares of Common Stock for issuance under the 2018 Plan on a Registration Statement on Form S-8, filed with the Securities and Exchange Commission …Spectrum Pharmaceuticals focuses on developing and commercializing novel and targeted drug products, with a primary focus in oncology. ... The stock currently trades around $1.25 a share and ...This EMPLOYEE STOCK PURCHASE PLAN (the “Plan”) is hereby established by Spectrum Pharmaceuticals, Inc., a Delaware corporation (the “Company”) as of March 23, 2009.The Plan was amended and restated as of September 21, 2018.Performance Of the Best Pharma Stocks of 2023. Sun Pharmaceutical Industries; Sun Pharmaceutical Industries Limited is a speciality generic pharmaceutical company and is one of the Best Pharma Stocks to Buy in India 2023. The company is engaged in the business of manufacturing, developing, and marketing a range of generic …
Assertio Holdings Inc (NASDAQ: ASRT) will acquire Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) in an all-stock and contingent value rights (CVR) transaction. Under the terms of the agreement, each ...The seven products are Fusilev (levoleucovorin), Folotyn (pralatexate injection), Zevalin (ibritumomab tiuxetan), Marqibo (vincristine sulfate LIPOSOME injection), Beleodaq (belinostat) for injection, Evomela (melphalan) for injection, and Khapzory (levoleucovorin). The seven drugs had a combined sales of $76.4 million in the first three ...Under the terms of the agreement, at closing, Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own ...Fundamentals Market Capitalization, $K 211,403 Shares Outstanding, K 205,246 Annual Sales, $ 10,110 K Annual Income, $ -75,400 K 60-Month Beta 2.14 Price/Sales 20.90 Price/Cash Flow N/A Price/Book 7.89 Trade SPPI with: Price/Earnings ttm 0.00 Earnings Per Share ttm -0.37 Most Recent Earnings -0.02 on 05/09/23 Next Earnings Date 08/10/23Instagram:https://instagram. fidelity versus schwabvanguard ftse social index fundrocket dollarquarter worth Mar 7, 2023 · Spectrum Pharmaceuticals, Inc. (SPPI) stock is up 3.37% while the S&P 500 is lower by -1.68% as of 2:46 PM on Tuesday, Mar 7. SPPI is higher by $0.03 from the previous closing price of $0.89 on volume of 1,201,038 shares. Over the past year the S&P 500 is down -5.25% while SPPI is higher by 19.48%. Spectrum Equity provides growth capital and expertise to market leading companies. gold roadoblg stock forecast Spectrum Pharmaceuticals' stock drops after the company receives a dreaded CRL from the FDA for Evomela. What: Spectrum Pharmaceuticals ( SPPI), a biotech company that develops and commercializes ...Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance. inflection ai stock Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today financi ... Common stock, $0.001 par value ...Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 33.33% and 5.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?